Detalhe da pesquisa
1.
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer.
Oncologist
; 27(9): 716-e689, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552447
2.
Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
BMC Cancer
; 22(1): 47, 2022 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996412
3.
Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer.
Oncologist
; 25(12): e1864-e1868, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692450
4.
The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
Cancer
; 122(4): 521-33, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26587698
5.
Integrated Capecitabine-Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective Study.
Cardiovasc Intervent Radiol
; 47(1): 60-68, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38057498
6.
Quantifying the impact of the COVID-19 pandemic on gastrointestinal cancer care delivery.
Cancer Rep (Hoboken)
; 5(1): e1427, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137216
7.
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing.
Front Oncol
; 12: 859846, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35865463
8.
Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma.
JCO Precis Oncol
; 6: e2200060, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939771
9.
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma.
Cancer
; 117(14): 3187-92, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21264839
10.
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 5(7): 993-998, 2019 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120501
11.
Safety and Feasibility of Integrating Yttrium-90 Radioembolization With Capecitabine-Temozolomide for Grade 2 Liver-Dominant Metastatic Neuroendocrine Tumors.
Pancreas
; 47(8): 980-984, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028446
12.
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis.
Pancreas
; 46(9): 1121-1126, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28902781
13.
Peptide Receptor Radionuclide Therapy-Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors.
Clin Nucl Med
; 40(11): 845-50, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26284763
14.
A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.
Clin Cancer Res
; 19(22): 6286-95, 2013 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23983255
15.
Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer.
Cancer Chemother Pharmacol
; 71(6): 1485-91, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23532207
16.
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
Science
; 331(6024): 1612-6, 2011 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21436454
17.
Medical Oncology: Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer.
Nat Rev Clin Oncol
; 6(5): 250-1, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19390547